Selective cytotoxic activity of brefeldin A against human tumor cell lines.
Ishii
S
S
Pharmaceutical Research Laboratories, Meiji Seika Kaisha, Ltd., Yokohama, Japan.
Nagasawa
M
M
Kariya
Y
Y
Yamamoto
H
H
D000818:Animals; D000935:Antifungal Agents / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000627:therapeutic use*; D020126:Brefeldin A; D002460:Cell Line; D002470:Cell Survival / Q000187:drug effects; D003517:Cyclopentanes / Q000627:therapeutic use*; D004317:Doxorubicin / Q000627:therapeutic use; D004353:Drug Evaluation, Preclinical; D006801:Humans; D051379:Mice; D014407:Tumor Cells, Cultured / Q000187:drug effects*
D000935:Antifungal Agents; D000998:Antiviral Agents; D003517:Cyclopentanes; D020126:Brefeldin A; D004317:Doxorubicin